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Induced pluripotent stem (iPS) cells represent an attractive option for the derivation of patient-speciﬁc pluripotent cells for cell
replacementtherapiesaswellasdiseasemodeling.Tobecomeclinicallymeaningful,safeiPScellsneedtobegeneratedexhibitingno
permanent genetic modiﬁcations that are caused by viral integrations of the reprogramming transgenes. Recently, various experi-
mentalstrategieshavebeenappliedtoaccomplishtransgene-freederivationofiPScells,includingtheuseofnonintegratingviruses,
episomal expression, or excision of transgenes after reprogramming by site-speciﬁc recombinases or transposases. A straightfor-
ward approach to induce reprogramming factors is the direct delivery of either synthetic mRNA or biologically active proteins. We
previously reported the generation of cell-permeant versions of Oct4 (Oct4-TAT) and Sox2 (Sox2-TAT) proteins and showed
that Oct4-TAT is reprogramming-competent, that is, it can substitute for Oct4-encoding virus. Here, we explore conditions for
enhanced Sox2-TAT protein stabilization and functional delivery into somatic cells. We show that cell-permeant Sox2 protein can
be stabilized by lipid-rich albumin supplements in serum replacement or low-serum-supplemented media. Employing optimized
conditions for protein delivery, we demonstrate that Sox2-TAT protein is able to substitute for viral Sox2. Sox2-piPS cells express
pluripotency-associated markers and diﬀerentiate into all three germ layers.
1.Introduction
Pluripotent cells represent a most attractive source for both
cell repair in regenerative medicine and disease modeling in
basic biomedical research since they are able to diﬀerentiate
into every cell type of an adult organism. Until recently, early
embryonic stages of development represented the main
source of pluripotent cells, and thus, those cells were desig-
nated as embryonic stem (ES) cells. Nowadays, the artiﬁcial
derivation of pluripotent stem cells from somatic cells
becomes increasingly important. Induced pluripotent stem
(iPS)cellswereﬁrstgeneratedbyretrovirallyinducedectopic
expression of four transcription factors Oct4, Sox2, Klf-4,
and c-Myc in somatic cells [1]. Human iPS cells represent
an attractive option forthe derivation of pluripotent patient-
speciﬁc cells as no embryos are required for their generation.
However,crucialsafetyissueshavetobeaddressedinorderto
generate human iPS cells that are clinically useful. Soon after
identiﬁcation of the viral reprogramming protocol in mouse
cells [1] and its adaptation to human cells [2, 3], unwanted
side eﬀects such as tumorigenesis [4] became apparent.
Since the cause of tumor formation was ascribed to
random integration of the retroviral vectors and sustained
expression of transgenes after reprogramming, optimized
protocols were explored to circumvent the permanent inte-
gration of foreign DNA into the genome. One strategy
involves the excision of reprogramming transgenes employ-
ing DNA recombinases [5, 6] or transposases [7–10]. After
iPS derivation, transgenes can be deleted by a second round
of recombinase/transposase activation. However, further
laborious and cumbersome genetic methods are needed to
identify and conﬁrm transgene-free iPS clones. An alterna-
tive strategy is to utilize less-invasive genetic vectors that
do not integrate into the host genome. Repeated plasmid
transfection has been used for iPS induction albeit with a
very low eﬃciency [11]. Minicircle vectors lacking bacterial
DNA and thus enabling high transfection eﬃciency and
long ectopic expression were reported to reprogram as
well [12]. Moreover, transduction employing viruses that
do not integrate their genome into host cells such as
adenovirus [13] or Sendai virus [14]w e r ea p p l i e d .S m a l l
molecules that are able to translocate into cells and interfere2 Stem Cells International
with key signaling pathways have been identiﬁed to either
enhance the process of reprogramming [15, 16]o rr e p l a c e
[15, 17] single viral factors (for review, see [18]). The
repeated transfection of synthetic mRNA [19–21] or the
directdeliveryofreprogrammingproteins[22,23]represents
a straightforward but technically challenging approach to
achieve nongenetic iPS derivation.
Proteintransductiontechnologyhasbeenusedtodirectly
deliver numerous biologically active proteins into mam-
malian cells by modifying them with so-called cell-pene-
trating peptides (CPPs) or protein transduction domains
(PTDs). These relatively small peptides confer cell perme-
ability when linked to cargo molecules (for review, see
[24–26]). A highly basic CPP derived from the human
immunodeﬁciency virus type 1 (HIV-1) Tat (transactivator of
transcription) protein is often applied for cellular delivery
(TAT) [25–28]. PTDs have been used to generate cell-
penetratingversionsofvarioustranscriptionfactorsthatplay
major roles in cell diﬀerentiation including HoxB4 [27],
Pdx1 [28], Scl [29], Nkx2.2 [30], and Notch-ICD [31]. We
previously reported the derivation of cell-permeant versions
ofreprogrammingfactorsOct4andSox2[22].Oct4-TATand
Sox2-TAT were shown to speciﬁcally bind to DNA such as
the Oct4/Sox2 combined element in the Nanog promoter,
and both proteins compensate the RNAi-induced loss of
function after direct delivery into ES cells [22]. Moreover,
employing Sox2-TAT, it has been demonstrated that Sox2
has an essential function in the preimplantation mouse
embryo by facilitating establishment of the trophectoderm
lineage [32]. Zhou et al. used fusion protein derivatives of
reprogramming factors from E. coli for the derivation of
mouse ES-like cells, albeit with very low eﬃciency [23].
Kim et al. reported the use of cell extracts from transfected
HEK293 cells for the reprogramming of human newborn
ﬁbroblasts [33]. The recently reported use of ES cell extracts
to induce pluripotency in murine ﬁbroblasts[34]needs tobe
explored whether it can be adapted to human cells. In con-
clusion, a robust, standardized, and eﬃcient protocol for the
generation of protein-induced iPS cells from human adult
cells still needs to be developed.
Further optimization of protein transduction for cellular
reprogramming greatly depends on overcoming a major
bottleneck associated with protein transduction: stability
of recombinant factors under cell culture conditions. We
recently established optimized stabilization conditions for
Oct4-TAT and demonstrated the eﬃcient substitution for
Oct4-encoding virus by recombinant Oct4-TAT [36]. Here,
we explore conditions for enhanced Sox2-TAT protein
stabilization and delivery into somatic cells. We show that
cell-permeant Sox2 protein can be stabilized by lipid-rich
albumin supplements in serum replacement or low-serum-
supplemented media. Employing these conditions for pro-
tein delivery, we demonstrate that Sox2-TAT protein is able
t os u b s t i t u t ef o rv i r a lS o x 2 .
2. MaterialsandMethods
2.1. Protein Expression and Puriﬁcation. The pSESAME-
Sox2NTH expression plasmid [22] was transformed into
E. coli BL21 (DE3) gold strain (Stratagene, La Jolla, USA) by
heat shock at 30◦C and incubated for 1h in SOC medium
at 30◦C. Transformed bacteria were inoculated overnight at
30◦C with shaking at 140rpm in LB medium containing
50mg/mL carbenicillin. For protein expression, the over-
night culture was pelletized and resuspended in fresh TB
medium (terriﬁc broth)/50mg/mL ampicillin, 0.5% glucose
and incubated at 37◦C with shaking at 110rpm until an
OD600 of 1.5 was achieved. Protein expression was induced
by IPTG at a ﬁnal concentration of 0.5mM. Cells were
harvested by centrifugation, and cell pellets were stored at
−20◦C.
For puriﬁcation of His-tagged proteins, cell pellets were
thawed and resuspended in 20mL lysis buﬀer (50mM
Na2HPO4, 5mM Tris, pH 7.8, 500mM NaCl, and 10mM
imidazole) per 1L of expression culture. Cells were lysed by
application of 1mg/mL lysozyme (Sigma, Deisenhofen, Ger-
many), 10–15U/mL Benzonase (Novagen, Darmstadt, Ger-
many), and sonication. After centrifugation (17200g,
20min), the cleared lysate was incubated with Ni-NTA
agarosebeads (Qiagen,Hilden,Germany)(1mLofslurryfor
1L of bacterial expression culture) for 1h with rotation
at 4◦C. The slurry was packed into a column and washed
with 8 column volumes of wash buﬀer (50mM Na2HPO4,
5mM Tris, pH 7.8, 500mM NaCl, and 80mM imidazole).
The Sox2-TAT protein was eluted with 3 column volumes
of elution buﬀer (50mM Na2HPO4,5 m MT r i s ,p H7 . 8 ,
500mM NaCl, and 250mM imidazole).
2.2. Preparation of Transduction Media. Sox2-TAT eluate
fraction was supplemented with 7.5% serum replacement
and dialyzed against DMEM F12 over night at 4◦C. The
next day cell culture supplements were added to the dialyzed
fraction to a ﬁnal concentration of 2% FCS, 2.5% Albumax
II (200mg/mL), 7.5% serum replacement, 1% ITS, 0.1mM
nonessential amino acids, 1mM sodium pyruvate, 2mM L-
glutamine, 0.5mM β-mercaptoethanol, and 1000U/mL LIF.
The mixture was preconditioned in a water bath for 1h at
37◦C and cleared by centrifugation (5min at 2500g) and
sterile ﬁltration.
2.3. Cell Culture. Oct4-GiP MEFs [38]w e r ec u l t u r e di n
high-glucose DMEM (Invitrogen) with 10% FCS, 0.1mM
nonessentialaminoacids,1mMsodiumpyruvate,and2mM
L-glutamine. MEFs were trypsinized at 70–80% conﬂuence
and reseeded on tissues culture dishes coated with gelatin.
For reprogramming assays, MEFs were used to a maximum
of passage 4.
mESCswereculturedinDMEMF12(Invitrogen)supple-
mented with 2% FCS, 2.5% Albumax II (200mg/mL), 7.5%
serum replacement, 1% ITS, 0.1mM nonessential amino
acids, 1mM sodium pyruvate, 2mM L-glutamine, 0.5mM
β-mercaptoethanol, and 1000U/mL LIF. Cells were split
every 3 days and cultured on inactivated feeder cells.
2.4. Retroviral Infection and iPS Induction. Plasmids of
pMXs-Oct3/4, pMXs-Sox2 (positive control), pMXs-c-Myc
and pMXs-Klf4 were obtained from ADDGENE. The retro-
viruses were generated by the plat E packaging cell line asStem Cells International 3
previouslydescribed[39].Targetcellswereseededat10×104
cells per well in six-well plates. 24 hours after transfection,
the supernatant comprising the viruses was collected and
ﬁltered through a 0.45μm cellulose acetate ﬁlter. For substi-
tutionexperiments andfornegative controls,Oct4,Klf4, and
c-Myc were mixed in equal shares and supplemented with
polybrene (Millipore) to a ﬁnal concentration of 4μg/mL.
Positive controls additionally contained pMXs-Sox2 virus
and were treated alike. Oct4-GiP MEF cells were incubated
with viruses for 16 hours. Protein transduction experiments
began after the virus-containing supernatant had been
removed. After 5 days, cells were split onto irradiated feeder
cells. 11 days later, cells were ﬁxed with 4% PFA and analyzed
by ﬂuorescence microscopy. For the purpose of generating
stable iPS cell lines, reprogramming assays were cultured for
21 days under designated conditions. Subsequently, colonies
were picked and expanded monoclonally.
2.5. In Vitro Diﬀerentiation. Cells were harvested by
trypsinization and transferred to bacterial culture dishes.
Next, cells were grown in ES medium lacking LIF for 3 days.
The derived embryoid bodies were transferred to gelatine-
coated tissue dishes afterwards and incubated for another 3
days. In order to detect key marker expression speciﬁc for all
three germ layers, immunostainings with antibodies against
β-3-tubulin (TUJ1), smooth muscle actin (SMA), and α-
fetoprotein (AFP) were conducted.
2.6. RT-PCR. Total RNA was extracted using the RNAeasy
kit (Qiagen, Hilden, Germany) following the manufacturer’s
instructions.Subsequently,reversetranscriptionof1μgRN A
per sample was performed using the iScript cDNA Synthesis
Kit (Bio-Rad). In order to detect viral transgene expression,
the following primer pairs were used:
Oct4TGforw: CCCCACTTCACCACACTCTAC,
Oct4TGrev: TTTATCGTCGACCACTGTGC,
Klf4TGforw: AGGCACTACCGCAAACACAC,
Klf4TGrev: TTTATCGTCGACCACTGTGC,
Sox2TGforw: GCCCAGTAGACTGCACATGG,
Sox2TGrev: CCCCCTTTTTCTGGAGACTA,
c-MycTGforw: CAGAGGAGGAACGAGCTGAAG-
CGC,
c-MycTGrev: TTTGTACAAGAAAGCTGGGT.
For the detection of endogenous Oct4, Sox2, and Nanog, the
following primer pairs were used:
Oct4forw: TCTTTCCACCAGGCCCCCGGCTC,
Oct4rev: TGCGGGCGGACATGGGGAGATCC,
Sox2for: TAGAGCTAGACTCCGGGCGATGA,
Sox2rev: TTGCCTTAAACAAGACCACGAAA,
Nanogfor: CAGGTGTTTGAGGGTAGCTC,
Nanogrev: CGGTTCATCATGGTACAGTC.
PCR-program: 95◦C 2min, 95◦C3 0s e c ,6 0 ◦C3 0s e c ,7 2 ◦C
1min,72 ◦C 10min. Steps 2–4 are repeated 35 times.
3. Results
3.1. Puriﬁcation of Reprogramming-Competent Sox2 Fusion
Protein from Bacteria. We have previously shown that
recombinant Sox2 can be puriﬁed from E. coli as a TAT-
modiﬁed cell-permeant version, designated Sox2-TAT [22].
In particular, this fusion protein comprises an additional
exogenous nuclear localization sequence (NLS), a cell-
penetrating peptide TAT, and a carboxy-terminal Histidine-
tag for single-step puriﬁcation (Figure 1(a)). Sox2-TAT was
shown to speciﬁcally bind to DNA and to compensate for the
RNAi-inducedlossofactivityinEScells[22]andpreimplan-
tation embryos [32]; however, its capability to reprogram
somatic cells has not been assessed. In order to study the
reprogrammingactivityofSox2-TAT,wedecidedtocombine
the puriﬁed recombinant Sox2-TAT together with retro-
viruses encoding for Oct4, Klf4, and c-Myc to convert mouse
embryonic ﬁbroblasts (MEFs) into iPS cells (Figure 1(b)).
Sox2-TAT-transformed bacteria were lysed and subjected to
Ni-aﬃnitychromatography.Immunoblotting ofpuriﬁcation
fractions employing a His-speciﬁc antibody revealed that
Sox2-TAT is highly expressed in bacteria although the major-
ity of the recombinant protein remains in the insoluble frac-
tion (Figure 1(d)). However, the estimated 20% of protein
solubilized and detectable in the supernatant turned out to
be suﬃcient for further puriﬁcation. The elution from the
Ni-aﬃnity chromatography column yielded a Sox2-TAT-
containing fraction of about 70% purity (Figure 1(c)).
3.2. Deﬁning Optimal Conditions to Stabilize Sox2-TAT
Protein. Poor solubility and limited stability of recombinant
proteins under cell culture conditions represent a signiﬁcant
hurdle to the application of protein transduction technology.
On the one hand, serum components stabilize recombinant
proteins in cell culture media, but on the other hand, they
are known to inhibit interaction of transducible proteins
with cells and by this decrease the cellular uptake. In some
experimental settings, this can be overcome by applying the
transducible protein in serum-free media. We assessed the
stability of Sox2-TAT employing various cell culture con-
ditions. In serum-free media, Sox2-TAT precipitates almost
completely within 1 hour (Figure 2(a)). Serum components
have been shown to execute a positive eﬀect on the stability
of recombinant proteins [36, 40]. Therefore, we aimed
at stabilizing the protein by supplements like FCS, serum
replacement [35], and lipid-rich albumin fractions (Albu-
max). Supplementation with either 5% FCS or 2.5% Albu-
max showed a strong stabilizing eﬀect on Sox2-TAT in
culture media, while Sox2-TAT exhibited major decrease
in the presence of 7.5% SR. A combination of low FCS
(2%) together with 7.5% SR resulted in a stabilization
that was comparable to high FCS supplementation (5%)
(Figure 2(a)).
Next, we set out to analyze to which extent the stabilizing
supplements interfere with the protein transduction process.
To that aim, we used a well-established transduction read-
out system based on a cell-permeant version of the DNA
recombinase Cre [40]. A major feature of this protein trans-
duction system is that the eﬃciency of intracellular protein4 Stem Cells International
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Figure 1: Puriﬁcation of recombinant Sox2-TAT fusion protein and reprogramming setup. (a) The recombinant cell-permeant Sox2 fusion
protein [22] consists of the full-length Sox2 protein and a carboxy-terminally fused sequence of tags consisting of a nuclear localization
sequence (NLS), cell-penetrating peptide TAT, and a histidine-tag (H6) for single-step puriﬁcation. (b) Schematic representation of the
expression and puriﬁcation procedure and the reprogramming setup used in this study. After expression in E. coli, Sox2-TAT-containing cell
lysates are subjected to aﬃnitycolumnchromatographyemployingNi-NTAresin.PuriﬁedrecombinantSox2-TATproteiniselutedfromthe
column and its reprogramming competency assessed in combination with retroviruses encoding Oct4, Klf-4, and c-Myc. (c, d) Biochemical
analysis of Sox2-TAT puriﬁcation from E. coli. The following fractions were subjected to SDS-PAGE analysis: crude lysate (CL), marker (M),
pellet (P), supernatant (SN), ﬂow-through (FT), washing buﬀer (W), and elution fraction (E). SDS gels were either stained using Coomassie
(c) or used for preparation of an immunoblot using anti-Sox2-speciﬁc antibody (d).
delivery can reliably be quantiﬁed by a Cre recombinase
reporterassay.WeusedtheCV1-5BCrereportercellline[37]
that speciﬁcally expresses β-galactosidase after Cre-mediated
recombination. Using this read-out system, we tested the
inﬂuence of FCS and SR on the transduction eﬃciency
(Figure 2(b)). 2μM of TAT-Cre in 5% FCS-supplemented
mediainducedrecombinationinapproximately35%ofcells,
whereas more than 90% of cellular targets were recombined
in medium containing 15% SR. Application of 1μMo fT A T -
Cre revealed a similar correlation: about 20% recombination
in the presence of FCS and 70% with SR (Figure 2(b)). These
data demonstrate that FCS in contrast to SR exhibits a strong
inhibition on protein transduction. Based on these results,
we established an optimized transduction protocol for iPS
derivation employing Sox2-TAT. We decided to apply a two-
step protocol to optimize both, protein stability and trans-
duction capacity. In a ﬁrst step, the eluate fraction was sup-
plemented with 7.5% SR and dialyzed against DMEM/F12.
Afterwards, the dialysis fraction was supplemented with FCS
(2%) and Albumax (2.5%). The optimized medium showed
protein stabilizing capacity during the dialysis and under cell
culture conditions in the same range as compared to SR and
FCS, respectively.
3.3. Reprogramming OKC-Infected Cells with Cell-Permeant
Sox2 Fusion Protein. We then assessed the reprogramming
activity of Sox2-TAT employing the optimized media con-
ditions. For that, we used a modiﬁcation of the classicalStem Cells International 5
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Figure 2:Eﬀectofmediasupplementsonthestabilityofcell-permeantSox2-TATfusionproteinandeﬃciencyofproteindelivery.(a)Ability
of media supplements to stabilize Sox2-TAT.Fetal calf serum (FCS),Albumax, and serum replacement (SR)were added to theeluate fraction
and subsequently dialyzed against DMEM-F12 media. Depicted are anti-Sox2-immunoblots of the dialysis fraction (D) and a stability test
of samples being taken after 1 hour (1h) and 6 hours (6h), respectively. (b) Inﬂuence of FCS, SR, and a combination of both on the
transduction eﬃciency. Protein transduction eﬃciencies were analyzed by quantifying the recombined cells after delivery of cell permeant
Cre-protein (TAT-Cre) into the CV1-5B Cre reporter cell line. Cells were treated with diﬀerent concentrations of TAT-Cre (0.25μM–2μM)
in transduction media supplemented with either 15% serum replacement, 5% FCS, or mixture of 2% FCS and 7.5% SR. To determine the
recombination activity, cells were ﬁxed and stained for β-galactosidase activity after 48 hours. Cre protein transduction and quantiﬁcation
of recombination in Cre reporter cells was performed as described previously [35].
four-factor viral reprogramming paradigm and aimed at
substituting the Sox2-encoding virus by Sox2-TAT protein
(Figure 3(a)). We transfected Oct4-GiP-transgenic MEFs
[38], which enable GFP-based monitoring of reprogram-
ming by reactivation of the Oct4 promoter, with viruses
encoding for Oct-4, Klf4, and c-Myc (OKC). OKC-MEFs
were initially cultivated for ﬁve days in medium containing
either200nMor400nMSox2-TAT. During thewholerepro-
grammingprocedure,wechangedtheprotein-supplemented
media every day to ensure a continuous delivery of the
recombinant reprogramming factor. At day ﬁve, cells were
split onto freshly plated feeder cells and either cultured in
normal media or further exposed to Sox2-TAT-containing
media for ﬁve more days (Figure 3(a)). First, iPS-like struc-
tures appeared after 9 days and formed well-deﬁned GFP-
positive colonies (Figure 3(b)). The viral transduction of
the three factors Oct4, Klf4, and c-Myc without Sox2-TAT
protein did not yield any GFP-positive colony (Figure 3(b)).
GFP+ colonies were quantiﬁed at day 16. We counted eight
GFP+ colonies in wells containing cells treated with 400nM
Sox2-TATforﬁvedays.ProlongedincubationwithSox2-TAT
until day 10 did not result in a marked increase of colony
numbers. Instead, the number of colonies slightly decreased
eventually due a strict time window required for Sox2 appli-
cation. The application of 200nM Sox2-TAT for ﬁve and ten
days yielded no and just one GFP+ colony, respectively
(Figure 3(c)), indicating that the Sox2-TAT concentration is
a limiting factor. We aimed at further increasing the
Sox2-TAT concentration by either dialysis against glycerol-
containing concentration buﬀer or ultraﬁltration; however,
beyond 400nM, the protein strongly precipitated in culture
mediaandinterferingwithcellulargrowth(datanotshown).
3.4. Sox2-piPS Cells Exhibit Pluripotency. Two Sox2-protein
iPS colonies were isolated and expanded for further charac-
terization, yielding Sox2-piPS-1 and Sox2-piPS-2 cell lines,
respectively. Both could be proliferated for at least 20
passages, and they maintained their Oct4 promoter-
driven GFP activity. Moreover, they stained positively for
the pluripotency-associated cell surface marker SSEA-1
(Figure 4(a)). Sox2-piPS-1 and Sox2-piPS-2 were subjected
to PCR analysis in order to assess transgenic integrations.
This analysis revealed that both lines carry integrated viral
transgenes, but no exogenous Sox2 (Figure 4(b)). Transgene
silencing represents a major hallmark of successful iPS
derivation. Thus, we applied RT-PCR analysis to detect
the transcripts of the transgenic reprogramming factors as
well as endogenous stemness factors. Both clones analyzed
exhibit no detectable transgenic Oct4, Sox2, Klf4, or c-Myc
(Figure 4(c)). The mRNA of endogenous Oct4, Sox2 and
Nanog, in contrast, was found as abundant as in the ES con-
trol cells, indicating complete silencing of exogenous factors
and reactivation of the endogenous grid of stemness. Finally,
we set out to conﬁrm the pluripotent status of Sox2-piPS-26 Stem Cells International
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Figure 3: Reprogramming of MEFs using cell-permeant Sox2-TAT protein. (a) Schematic presentation showing the timeline of
reprogramming setup. Oct4-GiP MEFs were infected with viruses encoding Oct4, Klf4, and c-Myc (OKC) at day 0. Starting at day 1 post
infection (p.i.), cells were incubated with Sox2-TAT for 5 and 10 days, respectively, changing the Sox2-TAT-supplemented media daily. (b)
Representativepicturesofcellstransducedwith200nMSox2-TATprotein(rightpanel)displayingphasecontrastandGFPchannel(inset)14
days p.i. OKC-infected cells treated with medium only served as controls (left panel). Scale bar = 100μm. (c) Quantiﬁcation of GFP-positive
colonies at day 16p.i. OKC-infected cells (−)a sw e l la sS O K C - i n f e c t e dc e l l s( + )s e r v e da sc o n t r o l s .
by spontaneous diﬀerentiation into embryoid bodies (EBs).
5-day old EBs were plated and analyzed for the appearance
of speciﬁc germ layer marker by staining against β-3-tubulin
(TUJ1), smooth muscle actin (SMA), and α-feto-protein
(AFP) (Figure 5). According to this analysis, Sox2-piPS-2
cells diﬀerentiated into all three germ layers, demonstrating
an unrestricted in vitro diﬀerentiation potential.
4. Discussion
In this study, we elaborated an optimized protocol for the
delivery of cell-permeant Sox2-TAT protein into mammalian
cells.PoorstabilityofSox2-TATundercellcultureconditions
represents a major bottleneck of Sox2 protein transduction.
Media supplements Albumax, SR, and FCS were analyzed
for their stabilizing eﬀect on Sox2-TAT. FCS was foundStem Cells International 7
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Figure 4: Cellular and molecular characterization of iPS clones derived by Sox2 protein transduction into OKC-MEFs. (a) Pictures of
isolatedcelllinesSox2-piPS-1(upperrow)andSox2-piPS-2(lowerrow)exhibitingbrightﬁeld(BF),stainingagainstpluripotency-associated
marker SSEA-1 and native GFP ﬂuorescence. Sox2-piPS-1 cell line was clonally isolated from 400nM Sox2-TAT treatment from day 1 to 5,
and Sox2-piPS-2 was derived from 200nM condition (day 5 to 10) Scale bar = 100μm. (b) PCR analysis of genomic DNA demonstrating
genomic integration of Oct4 and Klf4 transgenes. As expected, no transgenic Sox2 was detected in Sox2-piPS clones excluding possibility of
contamination. (c) RT-PCR analysis demonstrating transgene silencing in Sox2-piPS cells. Primers speciﬁc for transgenic Oct4, Sox2, Klf4,
and c-Myc were used. Additionally, we analyzed endogenous Oct4, Sox2, and Nanog transcripts. RNA preparations from infected (Inf.) and
uninfected MEFs as well as ES cells served as controls.8 Stem Cells International
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Figure 5: In vitro diﬀerentiation of Sox2-piPS cells. Spontaneously diﬀerentiated Sox2-piPS cells were stained for β-3-tubulin (TUJ1,
ectoderm) smooth muscle actin (SMA, Mesoderm), and α-fetoprotein (AFP, endoderm) as indicated. DAPI co-staining was performed
in every condition.
to stabilize Sox2-TAT, whereas the recombinant protein
rapidly precipitates in protein-free media. We used the
Cre protein transduction system [40] to assess the eﬀects
of media supplements SR, FCS, and Albumax on protein
transduction in a quantitative manner. It turned out that SR
has no deleterious eﬀect on cellular delivery, whereas FCS
strongly reduces the cellular uptake. Thus, in terms of
protein delivery, supplementation of SR is preferred over
FCS. However, since in contrast to ES and iPS cells ﬁbroblast
cells do not tolerate SR we employed a mixture of 7.5% SR
and 2% FCS. These media conditions represent an optimal
compromise for cultivation during protein-induced repro-
gramming of ﬁbroblasts.
Employing these optimized conditions, we demonstrate
that Sox2-TAT is able to substitute for a Sox2-encoding
virus during the OKC-viral induction of pluripotency in
ﬁbroblast cells. Stable Sox2-piPS cell lines could be generated
exhibiting major hallmarks of ES cells such as pluripotency-
associated marker expression and full diﬀerentiation poten-
tial in vitro. We found that proliferation of Sox2-piPS cells
does not depend on the continuous expression of the OKC
transgenes as judged by RT-PCR analysis. Notably, the trans-
duction of 200nM Sox2-TAT from day 5 to day 10 resulted
in the induction of one GFP+ colony (data not shown),
whereas treatment from day 1 to 5 did not give rise to any
colony, albeit the same concentration of protein was used.
Whether this observation hints at a speciﬁc time dependence
ofSox2duringthereprogrammingprocessorisaresultfrom
stochastic variation remains to be investigated. In general,
the eﬃciency of Sox2-piPS derivation is at least one order
of magnitude lower as compared to our previously reported
generationofOct4-piPScells[36].Fromthisobservation,we
conclude that although we provide proof-of-principle data,
that recombinant Sox2-TAT is reprogramming-competent,Stem Cells International 9
suﬃcient delivery of biologically active Sox2 protein into
the right cellular compartment represents a bottleneck for
protein-induced iPS derivation.
Further investigations are needed to accomplish robust
reprogramming of human adult cells such as ﬁbroblasts or
keratinocytes employing recombinant proteins. Optimized
expression and puriﬁcation protocols are needed to be
established that, for example, exploit the insoluble fraction
of recombinant Sox2-TAT by puriﬁcation under denaturing
conditions. Moreover, alternative expression hosts including
eukaryotic cells might enhance the derivation of soluble
native Sox2-TAT protein. Sox2 protein transduction might
not only be instrumental for the derivation of factor-free
iPS cells but also for the analysis of the reprogramming
mechanism by providing a tool to precisely determine the
duration and dose of Sox2 induction.
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